MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

drugmaker

  • Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Inc. said on Monday that it let go about 300 U.S. employees or about 1.2 percent of its total workforce, citing recent organizational changes to its commercial team. ...
    January 30, 2023BY Reuters
  • Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo International Plc. filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its ...
    August 17, 2022BY Reuters
  • Japan’s Shionogi Seeks Approval for COVID-19 Pill
    Japan’s Shionogi Seeks Approval for COVID-19 Pill
    TOKYO—Drugmaker Shionogi & Co. Ltd. has applied for approval to make and sell its oral COVID-19 treatment in ...
    February 26, 2022BY Reuters
  • Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    January 27, 2022BY Reuters
  • Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve ...
    January 18, 2022BY Reuters
  • Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Shares of Biogen Inc fell nearly 10 percent on Wednesday after the U.S. government announced limited coverage of ...
    January 13, 2022BY Reuters
  • Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    December 30, 2021BY Reuters
  • AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker ...
    September 29, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    ZURICH—Roche is looking for another location to carry out trials of its pill to fight COVID-19, after plummeting ...
    April 21, 2021BY Reuters
  • EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    BRUSSELS—Europe's fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such ...
    January 28, 2021BY Reuters
  • Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    NORMAN, Okla.—An Oklahoma judge on Aug. 26 found that Johnson & Johnson and its subsidiaries helped fuel the ...
    August 26, 2019BY The Associated Press
  • Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug ...
    November 11, 2017BY Fan Yu
  • Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which ...
    January 5, 2016BY The Associated Press
TOP NEWS
  • FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
    1hr By Kimberly Hayek
    FDA Investigates New Cyclospora Outbreak as Cases on Rise Across Midwest
  • Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
    2hr By Travis Gillmore
    Trump Denounces Communism, Touts Trump Accounts for Children in Georgia Speech
  • 124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
    3hr By Arthur Zhang
    124 Swiss Lawmakers Condemn Beijing’s Transnational Repression of Falun Gong
  • Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
    3hr By Epoch Video
    Live From Capitol Hill: ‘Unbroken’ Panel Discussion on Artistic Freedom
  • The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
    3hr By Sheramy Tsai
    The New Cholesterol Pill Isn’t for Everyone. Here’s How to Tell.
  • Senate Panel Advances Bill to Make Hospitals Compete on Price
    4hr By Lawrence Wilson
    Senate Panel Advances Bill to Make Hospitals Compete on Price
  • House Adopts Budget Blueprint for $95 Billion Reconciliation Package
    5hr By Jackson Richman
    House Adopts Budget Blueprint for $95 Billion Reconciliation Package
  • House Passes Congressional Stock Trading Ban
    5hr By Jackson Richman and Nathan Worcester
    House Passes Congressional Stock Trading Ban
  • US Signs Nuclear Cooperation Deal With Saudi Arabia
    5hr By Emel Akan
    US Signs Nuclear Cooperation Deal With Saudi Arabia
  • Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
    6hr By Jack Phillips
    Allergy Medication Recalled Over Possible ‘Life-Threatening’ Risks
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top